01 / Contract Profile
75N93021F00239 Federal Contract Award
Agency code 7529
THIS TASK ORDER IS TO DEVELOP AN OPTIMIZED PHASE 1 CGMP MANUFACTURING PROCESS FOR LIPID NANOPARTICLE (LNP) FABRICATION THAT ENABLE COVALENT COUPLING OF AN HIV-1 ENV TRIMER TO THE SURFACE OF THE LNP. A NON-GMP PROCESS RUN OF DRUG PRODUCT SHALL BE PERF
02 / Contract Size and Status
What is the recorded size and timing of this contract?
03 / Spending Trend
75N93021F00239 contract spending by fiscal year
Annual net obligations across the complete period available for this agency and PIID, from the first recorded fiscal year through the latest contract action.
Latest fiscal year obligations$0
FY 2025Net obligationsComplete recorded range
| Fiscal year | Net obligations | Actions | Change |
|---|---|---|---|
| FY 2021 | $1.62M | 2 | — |
| FY 2022 | $0 | 1 | −100.0% |
| FY 2023 | $635.0K | 2 | — |
| FY 2024 | $0 | 1 | −100.0% |
| FY 2025 | $0 | 1 | — |
04 / Federal Buyer
Which organization manages this contract?
| Department | Contracting agency | Contracting office |
|---|---|---|
| HEALTH AND HUMAN SERVICES, DEPARTMENT OF | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH NIAID |
05 / Contractor
Who holds this federal contract?
INTERNATIONAL AIDS VACCINE INITATIVE INC
UEI ZEJBC8JQM3P5 · CAGE 44YM6
06 / NAICS Industries
Which industries classify this contract?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| 541712 | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) | $2.25M | 7 | 100.0% |
07 / Products and Services
What products or services were purchased?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| AN11 | HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH | $2.25M | 7 | 100.0% |
08 / Place of Performance
Where is the work recorded?
NEW YORK, NEW YORK, NEW YORK, UNITED STATES
ZIP 100042743
09 / Contract Actions
What modifications and obligations were recorded?
| Signed date | Modification | Obligation | Contracting office | NAICS | PSC |
|---|---|---|---|---|---|
| Jun 10, 2025 | P00006 | $0 | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541712 | AN11 |
| May 7, 2024 | P00005 | $0 | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541712 | AN11 |
| Sep 13, 2023 | P00004 | $382.1K | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541712 | AN11 |
| Jun 7, 2023 | P00003 | $253.0K | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541712 | AN11 |
| Feb 28, 2022 | P00002 | $0 | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541712 | AN11 |
| Dec 2, 2021 | P00001 | $19.9K | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541712 | AN11 |
| Aug 31, 2021 | Base action | $1.60M | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541712 | AN11 |
10 / Reading the Contract
How should this award record be interpreted?
Read the PIID as a transaction history, not as a single purchase price. Net obligations combine the base action with later increases, reductions, corrections, and deobligations recorded under the same contract.
Verify the buyer
Agency and office identify who manages the procurement relationship.
Follow modifications
Each action can change funding, scope, dates, or administrative terms.
Compare the market
Use NAICS, PSC, and the contractor profile to identify related buyers and competitors.